This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

192 Resources
192 Resources
192 Resources
    Date
  1. Subcutaneous DMPA (DMPA-SC) is a three-month injectable contraceptive that is easy to use and uniquely suited for self-injection. Demonstration and practice injections are a key part of training programs for both health workers and self-injecting clients. Based on lessons learned in five countries, this memo summarizes PATH’s recommendations regarding devices for injection demonstration and practice, injection practice models, and waste disposal.This memo is included as part of PATH's training materials for facility- and community-based family planning providers.For more information, please visit www.path.org/dmpa-sc, sign up for our newsletter or email FPoptions@path.org.
    Published: March 2020
    Type: Resource Page
  2. Training and supervising health workers is one of the biggest challenges and cost drivers when introducing and bringing to scale a new contraceptive method or service delivery innovation. By leveraging digital platforms, family planning programs can integrate new approaches that help reduce the costs, time, and inconvenience associated with traditional classroom training.PATH has recently developed digital training resources for health workers and clients learning to administer the injectable contraceptive, subcutaneous DMPA (DMPA-SC). These resources are intended for health workers who provide family planning services in private, public, or community-based sectors.A 10-lesson DMPA-SC eLearning course is available in English and French and can be taken on computer or mobile device with internet access. Content includes an emphasis on informed choice counseling, new lessons on calculating the injection date and conducting follow-up visits, and updated information on training clients to self-inject.In addition to the eLearning course, PATH and John Snow, Inc. have developed short 5- to 7-minute training videos for both self-injection clients and health workers learning to administer DMPA-SC. Available in English and French, the videos can be translated or adapted to fit in program contexts.If you are interested in introducing DMPA-SC digital training approaches in your program, please contact the DMPA-SC Access Collaborative at FPoptions@path.org.
    Published: March 2020
    Type: Resource Page
  3. Planning for and addressing supply chain challenges is part of achieving contraceptive security—ensuring clients can choose, access, and use family planning methods. This brief provides an overview of supply chain considerations for countries that are introducing or scaling up the injectable contraceptive subcutaneous DMPA (DMPA-SC) within the range of options available in their family planning programs.For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.
    Published: March 2020
    Type: Resource Page
  4. The DMPA-SC Evidence to Practice meetings in 2018 and 2019 have gathered together family planning experts, including ministry officials, partners, and donors from more than 20 countries. Participants met to develop country strategies for increasing voluntary access to subcutaneous DMPA (DMPA-SC) within a wide range of contraceptive methods and to inform related policy decisions with current evidence. These reports summarize the plenaries, presentations, and discussions held to inform country planning. For more information, visit DMPA-SC Evidence to Practice: Increasing access, empowering women; sign up for our newsletter; or email FPoptions@path.org.
    Published: February 2020
    Type: Resource Page
  5. A synthesis of the white paper on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the evidence; and forthcoming evidence.
    Published: December 2019
    Type: Resource Page
Load more